D Path’s QPOR™ Platform Selected to Predict Patients’ Responses to TherapyNEWTON, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- 4D ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced publication of a landmark study in the ...

The phase 2a trial showed GR-0621 met primary and secondary endpoints, demonstrating safety and efficacy over 12 weeks. Phase 2a data show oral GRI-0621 was safe and improved immune and fibrosis ...

Researchers have discovered novel biomarkers that could allow doctors to detect endometriosis in its earliest stages through ...

Trastuzumab-based regimens were the primary treatment for older adults with advanced HER2-positive gastric cancer before immunotherapy became standard. The study highlights substantial economic ...

HPV status, particularly combined p16 and HPV positivity, is vital for patient selection in de-escalation strategies for ...

A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including ...

Recreational physical activity may be associated with breast tissue composition and biomarkers of stress in adolescent girls, ...

A small set of common blood biomarkers predicts which older adults will develop specific combinations of chronic diseases - and how quickly, a new study from Karolinska Institutet published in Nature ...

Mental illness is a significant cause of morbidity and mortality globally, with its burden continually increasing. The World Health Organization emphasizes the urgent need for accessible and scalable ...